Single Cell Genotypic and Phenotypic Analysis of Measurable Residual Disease in Acute Myeloid Leukemia

被引：3

作者：

Robinson, Troy ^{[1
,2
]}

Bowman, Robert L. ^{[2
,3
]}

Persaud, Sonali ^{[2
]}

Liu, Ying ^{[4
,5
]}

Gao, Qi ^{[6
]}

Zhang, Jing-Ping ^{[7
]}

Sun, Xiaotian ^{[6
]}

Sciambi, Adam ^{[8
]}

Llanso, Aaron ^{[9
]}

Famulare, Christopher ^{[10
]}

Goldberg, Aaron D. ^{[11
]}

Dogan, Ahmet ^{[6
]}

Roshal, Mikhail ^{[6
]}

Levine, Ross L. ^{[2
,10
,11
,12
]}

Xiao, Wenbin ^{[2
,6
,10
]}

机构：

[1] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, New York, NY 10021 USA

[4] Mem Sloan Kettering, Hematopathol Serv, Dept Pathol & Lab Med, New York, NY USA

[5] Mem Sloan Kettering, Mol Diagnost Serv, Dept Pathol & Lab Med, New York, NY USA

[6] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Hematopathol Serv, New York, NY USA

[7] Mem Sloan Kettering Canc Ctr, Dept Pathol, Hematopathol Serv, New York, NY 10021 USA

[8] Mission Bio Inc, San Francisco, CA USA

[9] Mission Bio, San Francisco, CA USA

[10] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, New York, NY 10021 USA

[11] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA

[12] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-166501

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2275 / 2277

页数：3

共 50 条

[41] Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns
Bozic, Tanja
Kuo, Chao-Chung
Hapala, Jan
Franzen, Julia
Eipel, Monika
Platzbecker, Uwe
Kirschner, Martin
Beier, Fabian
Jost, Edgar
Thiede, Christian
Wagner, Wolfgang
LEUKEMIA, 2022, 36 (01) : 80 - 89
[42] Measurable Residual Disease Conversion Rate with Consolidation Chemotherapy in Acute Myeloid Leukemia
Gaut, Daria
Oliai, Caspian
Boiarsky, Jonathan
Zhang, Shiliang
Azenkot, Tali
Kennedy, Vanessa E.
Khanna, Vishesh
Gutierrez, Karla Olmedo
Shukla, Navika D.
Moskoff, Benjamin
Patel, Anand Ashwin
Jeyakumar, Deepa
Mannis, Gabriel N.
Logan, Aaron C.
Jonas, Brian A.
Schiller, Gary J.
BLOOD, 2022, 140 : 3374 - 3376
[43] Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Gang, Margery
Othus, Megan
Walter, Roland B.
CELLS, 2025, 14 (04)
[44] Measurable Residual Disease Analysis by Flow Cytometry and Correlation With Molecular Measurable Residual Disease in Acute Promyelocytic Leukemia
Wen, Zhihao
Xue, Xinran
Li, Shuhua
Liu, Yu
Jin, Yongmei
Jiang, Nenggang
Liao, Hongyan
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2025, 149 (03) : 262 - 270
[45] Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia
Dillon, Laura W.
Higgins, Jake
Nasif, Hassan
Othus, Megan
Beppu, Lan
Smith, Thomas H.
Schmidt, Elizabeth
Valentine III, Charles C.
Salk, Jesse J.
Wood, Brent L.
Erba, Harry P.
Radich, Jerald P.
Hourigan, Christopher S.
REVISTA CHILENA DE LITERATURA, 2024, (109): : 401 - 410
[46] Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia
Maiti, Abhishek
DiNardo, Courtney D.
Wang, Sa A.
Jorgensen, Jeffrey
Kadia, Tapan M.
Daver, Naval G.
Short, Nicholas J.
Yilmaz, Musa
Pemmaraju, Naveen
Borthakur, Gautam
Bose, Prithviraj
Issa, Ghayas C.
Ferrajoli, Alessandra
Jabbour, Elias J.
Jain, Nitin
Garcia-Manero, Guillermo
Ohanian, Maro
Takahashi, Koichi
Montalban-Bravo, Guillermo
Masarova, Lucia
Burger, Jan A.
Thompson, Philip A.
Verstovsek, Srdan
Sasaki, Koji
Andreeff, Michael
Rausch, Caitlin R.
Montalbano, Kathryn S.
Pierce, Sherry
Qiao, Wei
Ning, Jing
Kantarjian, Hagop M.
Konopleva, Marina Y.
Ravandi, Farhad
BLOOD ADVANCES, 2021, 5 (07) : 1876 - 1883
[47] Measurable residual disease response in acute myeloid leukemia treated with venetoclax and azacitidine.
Pratz, Keith
Jonas, Brian Andrew
Pullarkat, Vinod
Recher, Christian
Schuh, Andre C.
Thirman, Michael J.
Garcia, Jacqueline Suen
Dinardo, Courtney Denton
Vorobyev, Vladimir
Fracchiolla, Nicola
Yeh, Su-Peng
Jang, Jun Ho
Ozcan, Muhit
Yamamoto, Kazuhito
Illes, Arpad
Zhou, Ying
Dail, Monique
Chyla, Brenda
Potluri, Jalaja
Dohner, Hartmut
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[48] Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia
Dillon, Laura W.
Higgins, Jake
Nasif, Hassan
Othus, Megan
Beppu, Lan
Smith, Thomas H.
Schmidt, Elizabeth
Valentine III, Charles C.
Salk, Jesse J.
Wood, Brent L.
Erba, Harry P.
Radich, Jerald P.
Hourigan, Christopher S.
HAEMATOLOGICA, 2024, 109 (02) : 401 - 410
[49] Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia
Dillon, Laura W.
Hayati, Sheida
Roloff, Gregory W.
Tunc, Ilker
Pirooznia, Mehdi
Mitrofanova, Antonina
Hourigan, Christopher S.
HAEMATOLOGICA, 2019, 104 (02) : 297 - 304
[50] Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia
Buccisano, Francesco
Dillon, Richard
Freeman, Sylvie D.
Venditti, Adriano
CANCERS, 2018, 10 (07)

← 1 2 3 4 5 →